Research Study to Look at How Well Cagrilintide Together With Semaglutide Works in People With Type 2 Diabetes

NCT04982575 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

92

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: Semaglutide 2.4 mg
DRUG: Cagrilintide 2.4 mg
DRUG: Placebo (semaglutide)
DRUG: Placebo (cagrilintide)

Sponsor

Novo Nordisk A/S